John CPA - T2 Biosystms Chief Officer
| TTOODelisted Stock | USD 0.18 0.05 21.74% |
Insider
John CPA is Chief Officer of T2 Biosystms
| Age | 67 |
| Phone | 781 761 4646 |
| Web | https://www.t2biosystems.com |
T2 Biosystms Management Efficiency
The company has return on total asset (ROA) of (0.9046) % which means that it has lost $0.9046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.2214) %, meaning that it created substantial loss on money invested by shareholders. T2 Biosystms' management efficiency ratios could be used to measure how well T2 Biosystms manages its routine affairs as well as how well it operates its assets and liabilities.T2 Biosystms currently holds 49.5 M in liabilities with Debt to Equity (D/E) ratio of 6.64, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. T2 Biosystms has a current ratio of 1.83, which is within standard range for the sector. Debt can assist T2 Biosystms until it has trouble settling it off, either with new capital or with free cash flow. So, T2 Biosystms' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like T2 Biosystms sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TTOO to invest in growth at high rates of return. When we think about T2 Biosystms' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Sandy Pound | Thermo Fisher Scientific | N/A | |
| JoseCarlos GutierrezRamos | Danaher | 63 | |
| Emily Hubbard | iSpecimen | N/A | |
| Joseph Holmes | Thermo Fisher Scientific | 45 | |
| BBus CA | Intelligent Bio Solutions | 60 | |
| Scott Ericksen | Illumina | 52 | |
| Jill Mullan | iSpecimen | 59 | |
| Alex Arzeno | Intelligent Bio Solutions | N/A | |
| Kevin Kempskie | Waters | N/A | |
| David MD | iSpecimen | N/A | |
| Christopher Bouda | Danaher | N/A | |
| Keeley Aleman | Waters | 47 | |
| Carissa Rollins | Illumina | 54 | |
| Maria JD | bioAffinity Technologies, | 69 | |
| Gianluca Pettiti | Thermo Fisher Scientific | 45 | |
| Dawn Michelle | iSpecimen | N/A | |
| Susan Tousi | Illumina | 55 | |
| Jiang Wei | Waters | N/A | |
| Belinda Hyde | Waters | 53 | |
| Alexander MD | Illumina | 47 | |
| Xavier MS | bioAffinity Technologies, | 55 | |
Management Performance
| Return On Equity | -6.22 | ||||
| Return On Asset | -0.9 |
T2 Biosystms Leadership Team
Elected by the shareholders, the T2 Biosystms' board of directors comprises two types of representatives: T2 Biosystms inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TTOO. The board's role is to monitor T2 Biosystms' management team and ensure that shareholders' interests are well served. T2 Biosystms' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, T2 Biosystms' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Roger Smith, Senior Development | ||
| Aparna MD, Chief Board | ||
| Kelley Morgan, Chief Officer | ||
| BSc III, CEO President | ||
| Michael Esq, Sr Counsel | ||
| Brett Giffin, Chief Officer | ||
| Alec Barclay, Senior Vice President - Operations | ||
| John CPA, Chief Officer |
TTOO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is T2 Biosystms a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.22 | ||||
| Return On Asset | -0.9 | ||||
| Operating Margin | (4.91) % | ||||
| Current Valuation | 21.91 M | ||||
| Shares Outstanding | 21.04 M | ||||
| Shares Owned By Insiders | 10.17 % | ||||
| Shares Owned By Institutions | 73.51 % | ||||
| Number Of Shares Shorted | 826.91 K | ||||
| Price To Earning | (2.04) X | ||||
| Price To Book | 14.50 X |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystms check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystms' history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |